OBSEVA SA Chart calendar ObsEva SA
e24d25c5ae00632eb3.MVFAPxvIYnJJhL35Gs7tS1vRcBvZJWh-OTy_DWv5R4w.Awg4S1O_NBx4tI63b62gBCzlBja4cFlLdUTMflKpMul-JhVFIok1CH_85A~b82a982a2b6e378b844d549b0aa23fd4
Past events on ObsEva SA
| 2024-06-26 | Annual General Meeting |
| 2022-12-01 04:01 pm | Q3 2022 Earnings Release |
| 2022-08-17 04:01 pm | Interim 2022 Earnings Release |
| 2022-05-24 10:30 am | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-18 10:30 am | Annual General Meeting |
| 2022-05-17 | Society Of Endometriosis And Uterine Disorders Congress |
| 2022-05-17 08:00 am | Q1 2022 Earnings Call |
| 2022-05-17 01:00 am | Q1 2022 Earnings Release |
| 2022-05-10 | International Society Of Gynecological Endocrinology World Congress |
| 2022-05-08 12:15 pm | American College of Obstetricians and Gynecologists Clinical and Scientific Meeting - Oral No A107 |
| 2022-05-06 04:00 pm | American College of Obstetricians and Gynecologists Clinical and Scientific Meeting - Poster No A108 |
| 2022-05-06 04:00 pm | American College of Obstetricians and Gynecologists Clinical and Scientific Meeting - Poster No A106 |
| 2022-05-06 04:00 pm | American College of Obstetricians and Gynecologists Clinical and Scientific Meeting - Poster No A104 |
| 2022-05-06 04:00 pm | American College of Obstetricians and Gynecologists Clinical and Scientific Meeting - Poster No A105 |
| 2022-03-10 01:00 am | FY 2021 Earnings Release |
| 2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference |
| 2022-01-06 08:00 am | EDELWEISS Phase-3 Trial Results Call |
| 2022-01-04 | LifeSci Partners Corporate Access Event |
| 2021-12-10 11:30 am | Society of Endometriosis and Uterine Disorders Congress |
| 2021-12-10 10:30 am | Society of Endometriosis and Uterine Disorders Congress |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,02 0,01 169.3% | 0,02 0,01 161.44% | 0,02 0,00 307.67% | 20,1 20,1 0% |
|
EBITDA Million USD | Released Forecast Spread | -77,0 -80,0 3.67% | -106 -115 7.51% | -79,0 -83,0 4.84% | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -77,2 -78,5 1.67% | -107 -115 6.8% | -79,7 -84,2 5.4% | -54,5 -52,5 -3.77% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -76,8 -77,5 0.96% | -109 -114 4.3% | -82,9 -87,1 4.78% | -58,2 -55,1 -5.65% |
|
Net income Million USD | Released Forecast Spread | -76,8 -77,6 1% | -109 -117 6.88% | -83,0 -87,8 5.51% | -58,4 -55,1 -5.9% |
|
EPS USD | Released Forecast Spread | -1,91 -1,89 -0.82% | -2,49 -2,66 6.32% | -1,67 -1,78 6.13% | -0,78 -0,73 -6.85% |
| Announcement Date | 05/03/19 | 05/03/20 | 05/03/21 | 10/03/22 |
Quarterly results
| Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 33.33% | 20,1 0,00 502350% | 0,01 0,00 25% | 2,24 3,70 -39.59% | 2,61 0,00 104380% | 3,71 2,51 48.18% |
|
EBIT Million USD | Released Forecast Spread | -18,4 -17,2 -6.6% | 1,53 -16,5 109.29% | -18,0 -16,0 -12.38% | -10,6 -14,4 26.45% | -31,4 -14,2 -121.35% | -0,63 -6,25 89.93% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,1 -18,1 -5.52% | 0,84 -16,8 104.97% | -19,9 -16,8 -18.52% | -11,7 -15,6 24.88% | -32,7 -15,2 -115.63% | -12,1 -10,5 -15.27% |
|
Net income Million USD | Released Forecast Spread | -19,1 -18,1 -5.69% | 0,82 -16,8 104.86% | -20,0 -16,8 -19.36% | -11,8 -15,7 24.77% | -32,8 -15,2 -115.8% | -12,1 -10,5 -14.6% |
|
EPS USD | Released Forecast Spread | -0,25 -0,26 1.96% | 0,01 -0,22 104.55% | -0,26 -0,22 -18.18% | -0,14 -0,20 28.81% | -0,39 -0,17 -126.09% | -0,13 -0,10 -25.81% |
| Announcement Date | 05/08/21 | 04/11/21 | 10/03/22 | 17/05/22 | 17/08/22 | 01/12/22 |
More events
Past sector events for ObsEva SA
| 2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
| 2024-07-08 | LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-07-07 | TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release |
| 2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
| 2024-06-06 | LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-06-06 | TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release |
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
